akhmentayeva-d 1

1. Inclisiran in Dyslipidemia with High Residual Platelet Reactivity
2. Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody–drug conjugates, and clinical trial innovations
3. Residual Platelet Reactivity and Dyslipidemia in Post-CABG Patients Undergoing Repeat Revascularization: Insights from Kazakhstan
1